Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis.

Jiao D, Cai Z, Choksi S, Ma D, Choe M, Kwon HJ, Baik JY, Rowan BG, Liu C, Liu ZG.

Cell Res. 2018 Aug;28(8):868-870. doi: 10.1038/s41422-018-0058-y. Epub 2018 Jun 25. No abstract available.

PMID:
29941926
2.

Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression.

Anbalagan M, Sheng M, Fleischer B, Zhang Y, Gao Y, Hoang V, Matossian M, Burks HE, Burow ME, Collins-Burow BM, Hangauer D, Rowan BG.

Mol Cancer Res. 2017 Nov;15(11):1491-1502. doi: 10.1158/1541-7786.MCR-16-0297-T. Epub 2017 Jul 27.

PMID:
28751463
3.

Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation.

Conger AK, Martin EC, Yan TJ, Rhodes LV, Hoang VT, La J, Anbalagan M, Burks HE, Rowan BG, Nephew KP, Collins-Burow BM, Burow ME.

Noncoding RNA. 2016 Sep 21;2(3). pii: E8. doi: 10.3390/ncrna2030008.

4.

Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.

Liu S, Zhang Q, Chen C, Ge D, Qu Y, Chen R, Fan YM, Li N, Tang WW, Zhang W, Zhang K, Wang AR, Rowan BG, Hill SM, Sartor O, Abdel-Mageed AB, Myers L, Lin Q, You Z.

Oncotarget. 2016 Mar 22;7(12):13651-66. doi: 10.18632/oncotarget.7296.

5.

Human Adipose Tissue-Derived Stromal/Stem Cells Promote Migration and Early Metastasis of Head and Neck Cancer Xenografts.

Rowan BG, Lacayo EA, Sheng M, Anbalagan M, Gimble JM, Jones RK, Joseph WJ, Friedlander PL, Chiu ES.

Aesthet Surg J. 2016 Jan;36(1):93-104. doi: 10.1093/asj/sjv090. Epub 2015 Jun 10.

PMID:
26063833
6.

Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer.

Anbalagan M, Rowan BG.

Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:264-72. doi: 10.1016/j.mce.2015.01.016. Epub 2015 Jan 15. Review.

PMID:
25597633
7.

Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer.

Dauchy RT, Xiang S, Mao L, Brimer S, Wren MA, Yuan L, Anbalagan M, Hauch A, Frasch T, Rowan BG, Blask DE, Hill SM.

Cancer Res. 2014 Aug 1;74(15):4099-110. doi: 10.1158/0008-5472.CAN-13-3156.

8.

Adipose stem cell therapy in cancer reconstruction: a critical review.

Alperovich M, Lee ZH, Friedlander PL, Rowan BG, Gimble JM, Chiu ES.

Ann Plast Surg. 2014 Sep;73 Suppl 1:S104-7. doi: 10.1097/SAP.0000000000000283. Review.

PMID:
25003407
9.

Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators.

Rhodes LV, Tate CR, Segar HC, Burks HE, Phamduy TB, Hoang V, Elliott S, Gilliam D, Pounder FN, Anbalagan M, Chrisey DB, Rowan BG, Burow ME, Collins-Burow BM.

Breast Cancer Res Treat. 2014 Jun;145(3):593-604. doi: 10.1007/s10549-014-2979-6. Epub 2014 May 9.

10.

Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts.

Rowan BG, Gimble JM, Sheng M, Anbalagan M, Jones RK, Frazier TP, Asher M, Lacayo EA, Friedlander PL, Kutner R, Chiu ES.

PLoS One. 2014 Feb 28;9(2):e89595. doi: 10.1371/journal.pone.0089595. eCollection 2014.

11.

ERα and ERK1/2 MAP kinase expression in microdissected stromal and epithelial endometrial cells.

Mohamed SA, Atta IS, Rowan BG, Desouki MM.

J Egypt Natl Canc Inst. 2014 Mar;26(1):37-41. doi: 10.1016/j.jnci.2013.09.001. Epub 2013 Nov 14.

12.

Human adipose-derived stromal/stem cells induce functional CD4+CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions.

Frazier TP, McLachlan JB, Gimble JM, Tucker HA, Rowan BG.

Stem Cells Dev. 2014 May 1;23(9):968-77. doi: 10.1089/scd.2013.0152. Epub 2014 Mar 11.

13.

C. elegans nuclear receptor NHR-6 functionally interacts with the jun-1 transcription factor during spermatheca development.

Gissendanner CR, Cardin D, Dubose CJ, El Sayed M, Harmson JS, Praslicka B, Rowan BG.

Genesis. 2014 Jan;52(1):29-38. doi: 10.1002/dvg.22723. Epub 2013 Nov 18.

14.

A novel mouse model of metastatic thyroid carcinoma using human adipose tissue-derived stromal/stem cells.

Kandil E, Hauch A, Friedlander P, Sheng M, Tsumagari K, Saeed A, Gimble JM, Rowan BG.

Anticancer Res. 2013 Oct;33(10):4213-7. Erratum in: Anticancer Res. 2014 Feb;34(2):1061. Sheng, Mei [added]. Anticancer Res. 2013 Nov;33(11):5211.

PMID:
24122984
15.

Insulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action.

Ge D, Dauchy RT, Liu S, Zhang Q, Mao L, Dauchy EM, Blask DE, Hill SM, Rowan BG, Brainard GC, Hanifin JP, Cecil KS, Xiong Z, Myers L, You Z.

J Pineal Res. 2013 Nov;55(4):377-87. doi: 10.1111/jpi.12084. Epub 2013 Aug 20.

16.

Body mass index affects proliferation and osteogenic differentiation of human subcutaneous adipose tissue-derived stem cells.

Frazier TP, Gimble JM, Devay JW, Tucker HA, Chiu ES, Rowan BG.

BMC Cell Biol. 2013 Aug 7;14:34. doi: 10.1186/1471-2121-14-34.

17.

Impact of low oxygen on the secretome of human adipose-derived stromal/stem cell primary cultures.

Frazier TP, Gimble JM, Kheterpal I, Rowan BG.

Biochimie. 2013 Dec;95(12):2286-96. doi: 10.1016/j.biochi.2013.07.011. Epub 2013 Jul 20.

PMID:
23880643
18.

Evolution and future prospects of adipose-derived immunomodulatory cell therapeutics.

McIntosh KR, Frazier T, Rowan BG, Gimble JM.

Expert Rev Clin Immunol. 2013 Feb;9(2):175-84. doi: 10.1586/eci.12.96. Review.

PMID:
23390948
19.

Genetic and epigenetic alterations of steroidogenic factor‑1 in ovarian tumors.

Miller S, Bhasin N, Urrego H, Moroz K, Rowan BG, Ramayya MS, Makridakis NM.

Int J Oncol. 2013 Feb;42(2):627-34. doi: 10.3892/ijo.2012.1758. Epub 2012 Dec 28.

20.

Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.

Marsden CG, Wright MJ, Carrier L, Moroz K, Rowan BG.

PLoS One. 2012;7(11):e47587. doi: 10.1371/journal.pone.0047587. Epub 2012 Nov 15.

21.

Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts.

Anbalagan M, Ali A, Jones RK, Marsden CG, Sheng M, Carrier L, Bu Y, Hangauer D, Rowan BG.

Mol Cancer Ther. 2012 Sep;11(9):1936-47. doi: 10.1158/1535-7163.MCT-12-0146. Epub 2012 Jul 10.

22.

Stable inhibition of specific estrogen receptor α (ERα) phosphorylation confers increased growth, migration/invasion, and disruption of estradiol signaling in MCF-7 breast cancer cells.

Huderson BP, Duplessis TT, Williams CC, Seger HC, Marsden CG, Pouey KJ, Hill SM, Rowan BG.

Endocrinology. 2012 Sep;153(9):4144-59. doi: 10.1210/en.2011-2001. Epub 2012 Jun 25.

23.

Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.

Bratton MR, Antoon JW, Duong BN, Frigo DE, Tilghman S, Collins-Burow BM, Elliott S, Tang Y, Melnik LI, Lai L, Alam J, Beckman BS, Hill SM, Rowan BG, McLachlan JA, Burow ME.

J Endocrinol. 2012 Jul;214(1):45-54. doi: 10.1530/JOE-12-0097. Epub 2012 May 4.

24.

Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models.

Zhang Q, Liu S, Ge D, Zhang Q, Xue Y, Xiong Z, Abdel-Mageed AB, Myers L, Hill SM, Rowan BG, Sartor O, Melamed J, Chen Z, You Z.

Cancer Res. 2012 May 15;72(10):2589-99. doi: 10.1158/0008-5472.CAN-11-3795. Epub 2012 Mar 28.

25.

Subcellular localization of total and activated Src kinase in African American and Caucasian breast cancer.

Anbalagan M, Moroz K, Ali A, Carrier L, Glodowski S, Rowan BG.

PLoS One. 2012;7(3):e33017. doi: 10.1371/journal.pone.0033017. Epub 2012 Mar 22.

26.

Post-translational modifications of nuclear receptors and human disease.

Anbalagan M, Huderson B, Murphy L, Rowan BG.

Nucl Recept Signal. 2012;10:e001. doi: 10.1621/nrs.10001. Epub 2012 Feb 27. Review.

27.

Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer.

Qi Y, Fu X, Xiong Z, Zhang H, Hill SM, Rowan BG, Dong Y.

PLoS One. 2012;7(2):e31539. doi: 10.1371/journal.pone.0031539. Epub 2012 Feb 14.

28.

"A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".

Marsden CG, Wright MJ, Carrier L, Moroz K, Pochampally R, Rowan BG.

BMC Cancer. 2012 Jan 10;12:10. doi: 10.1186/1471-2407-12-10.

29.

Methylseleninic acid is a novel suppressor of aromatase expression.

Gao R, Zhao L, Liu X, Rowan BG, Wabitsch M, Edwards DP, Nishi Y, Yanase T, Yu Q, Dong Y.

J Endocrinol. 2012 Feb;212(2):199-205. doi: 10.1530/JOE-11-0363. Epub 2011 Nov 29.

30.

KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.

Anbalagan M, Carrier L, Glodowski S, Hangauer D, Shan B, Rowan BG.

Breast Cancer Res Treat. 2012 Apr;132(2):391-409. doi: 10.1007/s10549-011-1513-3. Epub 2011 Apr 21.

PMID:
21509526
31.

Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.

Duplessis TT, Williams CC, Hill SM, Rowan BG.

Endocrinology. 2011 Jun;152(6):2517-26. doi: 10.1210/en.2010-1281. Epub 2011 Apr 19.

32.

Activation of autophagy in mesenchymal stem cells provides tumor stromal support.

Sanchez CG, Penfornis P, Oskowitz AZ, Boonjindasup AG, Cai DZ, Dhule SS, Rowan BG, Kelekar A, Krause DS, Pochampally RR.

Carcinogenesis. 2011 Jul;32(7):964-72. doi: 10.1093/carcin/bgr029. Epub 2011 Feb 11.

33.

Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.

Liu S, Qi Y, Ge Y, Duplessis T, Rowan BG, Ip C, Cheng H, Rennie PS, Horikawa I, Lustig AJ, Yu Q, Zhang H, Dong Y.

Mol Cancer Ther. 2010 Jul;9(7):2016-25. doi: 10.1158/1535-7163.MCT-09-0924. Epub 2010 Jun 22.

34.

A functional NR4A nuclear receptor DNA-binding domain is required for organ development in Caenorhabditis elegans.

Heard M, Maina CV, Morehead BE, Hoener MC, Nguyen TQ, Williams CC, Rowan BG, Gissendanner CR.

Genesis. 2010 Aug;48(8):485-91. doi: 10.1002/dvg.20646.

35.

A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.

Skliris GP, Nugent ZJ, Rowan BG, Penner CR, Watson PH, Murphy LC.

Endocr Relat Cancer. 2010 Jun 3;17(3):589-97. doi: 10.1677/ERC-10-0030. Print 2010 Sep.

36.

Human steroidogenic factor-1 (hSF-1) regulates progesterone biosynthesis and growth of ovarian surface epithelial cancer cells.

Ramayya MS, Sheng M, Moroz K, Hill SM, Rowan BG.

J Steroid Biochem Mol Biol. 2010 Mar;119(1-2):14-25. doi: 10.1016/j.jsbmb.2009.11.006. Epub 2010 Jan 4.

PMID:
20045459
37.

Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2.

Williams CC, Basu A, El-Gharbawy A, Carrier LM, Smith CL, Rowan BG.

BMC Biochem. 2009 Dec 31;10:36. doi: 10.1186/1471-2091-10-36.

38.

Breast tumor-initiating cells isolated from patient core biopsies for study of hormone action.

Marsden CG, Wright MJ, Pochampally R, Rowan BG.

Methods Mol Biol. 2009;590:363-75. doi: 10.1007/978-1-60327-378-7_23.

PMID:
19763516
39.

Detection of ERalpha-SRC-1 interactions using bioluminescent resonance energy transfer.

Duplessis TT, Koterba KL, Rowan BG.

Methods Mol Biol. 2009;590:253-63. doi: 10.1007/978-1-60327-378-7_16.

PMID:
19763509
40.

Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence.

Rhodes LV, Muir SE, Elliott S, Guillot LM, Antoon JW, Penfornis P, Tilghman SL, Salvo VA, Fonseca JP, Lacey MR, Beckman BS, McLachlan JA, Rowan BG, Pochampally R, Burow ME.

Breast Cancer Res Treat. 2010 Jun;121(2):293-300. doi: 10.1007/s10549-009-0458-2. Epub 2009 Jul 12.

41.

The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo.

Murphy LC, Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Penner C, Troup S, Begic S, Parisien M, Watson PH.

J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):90-5. doi: 10.1016/j.jsbmb.2009.01.017. Epub 2009 Feb 6. Review.

PMID:
19429437
42.

Cell growth characteristics, differentiation frequency, and immunophenotype of adult ear mesenchymal stem cells.

Staszkiewicz J, Frazier TP, Rowan BG, Bunnell BA, Chiu ES, Gimble JM, Gawronska-Kozak B.

Stem Cells Dev. 2010 Jan;19(1):83-92. doi: 10.1089/scd.2009.0051.

43.

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas.

Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Troup S, Begic S, Parisien M, Watson PH, Murphy LC.

Breast Cancer Res Treat. 2009 Dec;118(3):443-53. doi: 10.1007/s10549-008-0267-z. Epub 2008 Dec 23.

44.

Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.

Li Z, Carrier L, Belame A, Thiyagarajah A, Salvo VA, Burow ME, Rowan BG.

Breast Cancer Res Treat. 2009 Nov;118(1):33-43. doi: 10.1007/s10549-008-0216-x. Epub 2008 Oct 15.

PMID:
18855134
45.

Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells.

Li Z, Carrier L, Rowan BG.

Mol Cancer Ther. 2008 Sep;7(9):3056-63. doi: 10.1158/1535-7163.MCT-07-2142.

48.

Identification of novel proteins induced by estradiol, 4-hydroxytamoxifen and acolbifene in T47D breast cancer cells.

Al-Dhaheri MH, Shah YM, Basrur V, Pind S, Rowan BG.

Steroids. 2006 Nov;71(11-12):966-78. Epub 2006 Sep 1.

PMID:
16949628
50.

p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1.

Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S, Collins-Burow BM, Salvo VA, Zhu Y, Melnik LI, Lopez GN, Kushner PJ, Curiel TJ, Rowan BG, McLachlan JA, Burow ME.

Mol Endocrinol. 2006 May;20(5):971-83. Epub 2006 Jan 12.

PMID:
16410316

Supplemental Content

Loading ...
Support Center